Unichem Laboratories · NSE: UNICHEMLAB · BSE: 506690

Q1 FY21 results · Apr–Jun 2020

Unichem Laboratories reported revenue from operations of ₹317.27 crore (up 6.6% from Q1 FY20) and net profit of ₹2.43 crore for Q1 FY21 (Apr–Jun 2020), on a consolidated basis.

Consolidated · ₹ crore
Item	Q1 FY21	Q1 FY20	YoY	Q4 FY20	QoQ
Revenue from operations	317.27	297.74	+6.6%	320.23	−0.9%
Other income	16.71	26.26	−36.4%	11.82	+41.3%
Total income	333.98	324.00	+3.1%	332.05	+0.6%
Profit before share of associates & JVs and tax	7.00	(13.49)	Turned profit	(0.17)	Turned profit
Share of profit/(loss) of associates & JVs	0.04	(0.23)		0.61
Net profit for the period	2.43	(6.19)	Turned profit	(17.19)	Turned profit
EPS, basic (₹)	0.35	(0.88)	Turned profit	(2.44)	Turned profit
Net margin (%)	0.8	-2.1		-5.4

This company reports a share of profit/(loss) from associates and joint ventures. BSE’s filing format records that share after tax, so it is shown on its own line. The company’s own statement may add it before its “profit before tax” line.

Standalone · ₹ crore
Item	Q1 FY21	Q1 FY20	YoY	Q4 FY20	QoQ
Revenue from operations	240.77	232.52	+3.5%	216.07	+11.4%
Other income	18.73	27.98	−33.1%	19.13	−2.1%
Total income	259.50	260.50	−0.4%	235.20	+10.3%
Profit before tax	(7.55)	(7.03)	Loss widened	(11.54)	Loss narrowed
Net profit for the period	(7.55)	0.46	Turned loss	(11.55)	Loss narrowed
EPS, basic (₹)	(1.07)	0.07	Turned loss	(1.65)	Loss narrowed
Net margin (%)	-3.1	0.2		-5.3

Consolidated

Filed with BSE: 08 Aug 2020, 14:15 IST
Board meeting: 04 Aug 2020
Period: 01 Apr 2020 to 30 Jun 2020
Review status: Unaudited
Source: XBRL filing on BSE

Standalone

Filed with BSE: 08 Aug 2020, 14:15 IST
Board meeting: 04 Aug 2020
Period: 01 Apr 2020 to 30 Jun 2020
Review status: Unaudited
Source: XBRL filing on BSE